Psychiatric Treatment: Side Effects Basics

Slideshow

A quick primer on nomenclature, issues to consider, and switching.

Related Videos
Experts on MDD.
Experts on MDD.
Related Content

The Week in Review: September 25-29

September 30th 2023

Here's to a Psychedelic Revolution

April 9th 2022

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD

September 26th 2023

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

The Week in Review: September 25-29

September 30th 2023

Here's to a Psychedelic Revolution

April 9th 2022

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD

September 26th 2023

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

The Week in Review: September 25-29

September 30th 2023

Here's to a Psychedelic Revolution

April 9th 2022

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD

September 26th 2023

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023
© 2023 MJH Life Sciences

All rights reserved.